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The combination of reflectance, fluorescence, and Raman spectroscopy—termed multimodal
spectroscopy MMS—provides complementary and depth-sensitive information about tissue
composition. As such, MMS is a promising tool for disease diagnosis, particularly in atherosclerosis
and breast cancer. We have developed an integrated MMS instrument and optical fiber spectral
probe for simultaneous collection of all three modalities in a clinical setting. The MMS instrument
multiplexes three excitation sources, a xenon flash lamp 370–740 nm, a nitrogen laser 337 nm,
and a diode laser 830 nm, through the MMS probe to excite tissue and collect the spectra. The
spectra are recorded on two spectrograph/charge-coupled device modules, one optimized for visible
wavelengths reflectance and fluorescence and the other for the near-infrared Raman, and
processed to provide diagnostic parameters. We also describe the design and calibration of a unitary
MMS optical fiber probe 2 mm in outer diameter, containing a single appropriately filtered
excitation fiber and a ring of 15 collection fibers, with separate groups of appropriately filtered fibers
for efficiently collecting reflectance, fluorescence, and Raman spectra from the same tissue location.
A probe with this excitation/collection geometry has not been used previously to collect reflectance
and fluorescence spectra, and thus physical tissue models “phantoms” are used to characterize the
probe’s spectroscopic response. This calibration provides probe-specific modeling parameters that
enable accurate extraction of spectral parameters. This clinical MMS system has been used recently
to analyze artery and breast tissue in vivo and ex vivo. © 2009 American Institute of Physics.
DOI: 10.1063/1.3117832
I. INTRODUCTION
Spectroscopy is a promising means of extracting bio-
chemical and morphological information about tissue that is
relevant to disease progression and diagnosis.1,2 Raman
spectroscopy, which measures the molecular vibrations
of a sample, has been utilized previously to study
atherosclerosis,3 measure blood analytes,4 and detect dyspla-
sia and cancer in various tissues including the breast,5–7
cervix,8–10 prostate,11,12 and skin.13–15 By measuring changes
in scattering and absorption properties, diffuse reflectance
spectroscopy DRS has been used to track the progression
of disease in tissues of the colon,16,17 esophagus,18 cervix,19
and bladder.20,21 Similarly, intrinsic fluorescence spectros-
copy IFS, free of distortions due to scattering and absorp-
tion, which measures the emission of endogenous fluoro-
phores found in tissue, has been used to detect dysplasia in
the uterine cervix,19,22,23 adenomatous colon polyps,24,25 the
esophagus,18,26,27 and the oral cavity.28,29 Since these three
spectroscopic modalities provide complementary informa-
tion about tissue composition, their combination should pro-
vide useful information about disease status and its treat-
ment.
Several groups have developed their own spectroscopic
instrumentation and probes for tissue investigation.30,31 Our
laboratory has previously developed two separate clinical
spectroscopic instruments, briefly described in the next two
subsections, each with its own optical fiber probe for collect-
ing different spectroscopic modalities. The clinical Raman
instrument32 and probe33 have been developed for portable
real-time study of diseases such as atherosclerosis and breast
cancer. The fast excitation emission matrix FastEEM in-
strument and probe34,35 have been developed to extract DRS
and IFS spectra excited at multiple wavelengths, useful for
studying cancer in organs such as the cervix and oral cavity.
A. Clinical Raman system
Our laboratory has previously developed a compact
clinical Raman instrument for real-time tissue
spectroscopy.32 The instrument uses an 830 nm diode laser to
excite Raman scattering. The laser light is filtered and
coupled into an optical fiber Raman probe, which delivers to
and collects light from tissue. The Raman probe33 contains a
single excitation fiber surrounded by a ring of 15 collection
fibers, specialized filters on both the excitation and collection
fibers at the distal tip of the probe, and a ball lens at the tip
to optimize signal collection. The return light is passed
through a spectrograph and dispersed onto a charge-coupled
device CCD detector. The entire operation is fully auto-
mated and computer-controlled.
B. FastEEM system
Our laboratory has also developed the FastEEM instru-
ment for real-time reflectance and fluorescence tissue
spectroscopy.34–36 A fluorescence EEM is produced by
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means of a rotating wheel containing laser dyes, pumped by
a 308 nm XeCl excimer laser, which generates nine laser
pulses at excitation wavelengths ranging from 340 to 500 nm
which, including the 308 nm pulses, provides ten laser exci-
tation wavelengths in all. In addition, a xenon flash lamp
produces white light pulses for reflectance. An unfiltered op-
tical fiber probe delivers light to and collects it from the
tissue. This probe contains a single central excitation fiber
surrounded by a ring of six collection fibers, and an angled
quartz “optical shield” at the probe tip37 to provide a fixed
light delivery-collection geometry. Return light from the tis-
sue is transmitted by the collection fibers to a spectrograph/
CCD detector for analysis. The operation of the instrument is
automated via LABVIEW software.
C. Multimodal spectroscopy „MMS…
Previous studies demonstrated the diagnostic potential of
Raman, DRS, and IFS as separate spectroscopic modalities.
Recently, we have developed Raman, DRS, and IFS—or
MMS—as a combined technique to yield complementary
spectral and depth-sensitive information about tissue. DRS
provides information about tissue absorption and scattering,
IFS about tissue fluorophores, and Raman spectroscopy
about molecular tissue composition. In addition, the three
techniques utilize different portions of the wavelength range
covered, 300–1000 nm. Light penetration in tissue varies
substantially over this range, so the three modalities sample
different depths, thus providing depth-sensitive capability.
The depth-sensitive capability enables the measurement of
the sizes of structures in layered tissue, which can be critical
to disease diagnosis. For example, our laboratory envisions
using MMS to measure the thickness of the top layer fibrous
cap in diseased arteries relative to the size of the underlying
plaque core, which is critical to being able to assess the
propensity of the plaque to rupture and cause a heart attack
or stroke.38
We have obtained promising results using MMS for dis-
ease diagnosis, specifically in atherosclerosis39 and breast
cancer, with other organs also under investigation, and have
developed a portable instrument for delivery, collecting, and
processing the MMS data. In parallel, we have developed an
efficient unitary MMS probe for simultaneously collecting
spectra of all three modalities, thus eliminating sampling er-
ror. This paper describes the MMS system and the modeling
for accurately extracting disease-related spectral parameters.
II. SYSTEM DESCRIPTION
The clinical portable MMS instrument merges the de-
signs of the previously developed clinical Raman and
FastEEM systems. The design is modular. The MMS instru-
ment contains all the critical functionality of both systems,
with several improvements based on newer technology. A
schematic diagram is provided in Fig. 1.
A. Sources
The MMS instrument contains three excitation sources:
a Xe flash lamp L7684, Hamamatsu Corp., Bridgewater,
NJ, a white light source used to obtain diffuse reflectance
spectra DRS; a 337 nm N2 laser used to excite fluorescence
NL100, Stanford Research Systems, Sunnyvale, CA; and
an 830 nm diode laser used to excite Raman spectra Process
Instruments, Salt Lake City, UT. All are configured to be
triggerable externally through automated software. The Xe
lamp provides a 2.9 s full width half maximum FWHM
white light pulse, 1 J/pulse max, externally triggered by the
software. The light from the Xe lamp passes through a
370 nm long pass filter LP02–364RS-25, Semrock, Roch-
ester, NY and is then focused into a fiber; this filter guaran-
tees that the reflectance collected over the range 370–740 nm
is free of second order diffraction from the spectrograph
grating. The N2 laser provides externally triggered 3.5 ns
FWHM pulses of 337 nm light, 170 J per pulse, with a 10
Hz repetition rate. The light is focused into an optical fiber
by means of an UV-coated lens. The diode laser can be con-
figured to output a range of up to 500 mW of continuous-
wave 830 nm light driven by a user-specified analog signal.
The 830 nm laser light is filtered by an 830 nm bandpass
filter LL01–830–12.5, Semrock, Rochester, NY and gated
by a mechanical shutter LS6ZM2, Vincent Associates,
Rochester, NY before being focused into an optical fiber.
B. Coupling to the MMS probe
The excitation sources are coupled sequentially to the
MMS probe see Sec. III A for details using an optical fiber
switch FSM14, Piezo Jena, Germany. This is a microelec-
tromechanical systems MEMS device that provides supe-
rior coupling of the individual sources and interfaces simply
with the control software by means of a user-configurable
binary code. The switch contains a four optical fiber inputs
FIG. 1. Color online Schematic diagram of the MMS instrument. BF
=bandpass filter, LF=longpass filter, S=shutter, FL=focusing lens, OF
=optical fiber, FS=fiber switch, SP1=visible spectrograph, SP2=NIR spec-
trograph, iCCD=intensified CCD, and XTE CCD=thermoelectrically
cooled CCD.
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and a single optical fiber output with each fiber terminated
by a SubMiniature version A SMA connector. The outputs
of the Xe lamp, N2 laser, and diode laser are directly chan-
neled into three input fibers of the switch. The remaining
input channel is left vacant for a future light source. The
output fiber of the switch is connected to the MMS probe by
means of a SMA-to-SMA connector. The overall transmis-
sion efficiency of the switch is 60%, resulting from an
80% switching efficiency and an 80% SMA-to-SMA cou-
pling efficiency.
C. Detection
The MMS system uses two spectrograph/CCD modules,
one optimized for near infrared NIR detection Raman and
the other for visible wavelengths reflectance and fluores-
cence. The operation of both cameras is controlled by
modular LABVIEW drivers R3 Software, Princeton, NJ.
The distal tips of the ten collection fibers carrying the
Raman light are aligned in a linear array, effectively serving
as an entrance slit to the spectrograph Holospec f/1.8i, Kai-
ser Optical Systems, resulting in an 9 cm−1 spectral res-
olution. The fibers are encased in a modified male fixed con-
nection FC connector to ensure highly reproducible
alignment with the connector plate of the spectrograph. Any
spectral changes incurred by disconnecting and reconnecting
the linear array are found to be below the system’s spectral
resolution. The numerical aperture NA of the collection
fibers is matched to the spectrograph f / # =1.8 to conserve
throughput. The spectrograph contains an 830 nm notch filter
that further suppresses the elastically scattered Rayleigh light
and a holographic grating to disperse the Raman scattered
light onto a back-illuminated, deep-depletion CCD detector
with a 1340400 array of pixels Spec10 XTE, Princeton
Instruments/Acton, Acton, MA. The CCD detector has a 16
bit dynamic range and can be thermoelectrically cooled
within minutes to −90 °C, a significant practical improve-
ment over the older Raman system, which had a liquid nitro-
gen cooled CCD. Spectra are obtained by vertically binning
the signal from the ten collection fibers. Since the Raman
signals are relatively weak compared to ambient background,
and owing to an absence of gated detectors in the NIR re-
gion, all spectra are collected with the room lights off.
The five collection fibers carrying the reflectance or fluo-
rescence light are arranged vertically and coupled to a dif-
fraction grating spectrometer Spectra Pro 150, Princeton
Instruments/Acton, Acton, MA, resulting in an 6 nm
spectral resolution. The PIMAX camera has a 16 bit dynamic
range and is thermoelectrically cooled to −20 °C. The col-
lection fibers have individual male SMA adapters that con-
nect to corresponding female SMA adapters mounted to a
plate adjacent to the spectrograph; this insures easy repro-
ducibility when the MMS probe is disconnected from and
reconnected to the system. The collected light is then dis-
persed onto an intensified CCD detector PIMAX, Princeton
Instruments/Acton, Acton, MA. The CCD is operated in a
gated mode, where the intensifier is biased on for only a
short period of time 30 s extending from immediately
prior to immediately after each laser/white light pulse. The
short duration of this gate ensures that the background from
ambient light is negligible, although this is less of a concern
with the MMS instrument since the room lights are routinely
turned off, as is required for Raman signal collection.
D. Real-time software
The entire MMS system is controlled by a single user-
friendly interface developed in LABVIEW National Instru-
ments, Austin, TX. The control flow of the software for a
single MMS acquisition is presented in Fig. 2, describing the
timing by which the various sources and detectors are trig-
gered to collect the MMS spectra. The software platform
allows for calibration spectra to be taken and stored, pro-
vides easy operation of the experimental data collection and
storage, and provides instant feedback about the collected
spectra, fits, and extracted diagnostic spectral parameters.
The sources and cameras are triggered by two data acquisi-
tion DAQ cards 6062 and 6035E, National Instruments,
Austin, TX.
E. System calibration
In order to provide real-time data analysis and spectral
diagnosis, spectra for calibration and background subtraction
must be acquired prior to data collection. The Raman shift
axis is calibrated by collecting a spectrum from a known
Raman scatterer, 4-acetamidophenol Tylenol. The Raman
fiber background signal from the MMS probe is measured
through acquisition of a spectrum from a roughened alumi-
num block. The spectral response of the Raman collection
FIG. 2. Control flow of the MMS instrument software in which the Raman,
reflectance, and fluorescence signals are collected sequentially through the
optical fiber switch. Collection of the Raman signals is facilitated by open-
ing the laser shutter and triggering the camera to collect a spectrum for a
specified amount of time. Collection of the reflectance signal is facilitated
by appropriately triggering the Xe lamp and the camera gate. The fluores-
cence signal is collected by triggering the nitrogen laser and the camera
gate.
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system is obtained by recording the spectrum of a calibrated
tungsten white light source diffusely scattered by a reflec-
tance standard BaSO4. The wavelength of the reflectance
and fluorescence spectra is calibrated by recording a spec-
trum from a mercury lamp. Background calibration for re-
flectance and fluorescence is used to remove effects of CCD
dark current and stray light and is typically acquired by col-
lecting a spectrum from an opaque cup of de-ionized water.
The reflectance amplitude is calibrated by collecting a spec-
trum from a reflectance standard 20% reflectance standard,
Labsphere Inc., North Sutton, NH. To normalize the fluores-
cence spectra appropriately, the output from the nitrogen la-
ser through the MMS probe is noted with an energy meter.
The system is designed to be stable from day to day; thus
disconnecting and reconnecting the probe to the system do
not change the calibration parameters. However, different
MMS probes can have significantly different calibration pa-
rameters.
F. Data analysis
This section describes the data analysis steps for each
modality.
1. Raman
A sequence of steps is executed to extract quantitative
Raman information from the raw spectrum acquired at the
CCD. First, the data are corrected for the system spectral
response by dividing it by the white light spectrum. The
resulting data are then normalized to maximum peak height
and truncated to the biological Raman region of interest
appropriate to the models used in this study 686 to
1788 cm−1. Next, the fiber background from the tissue is
removed by subtracting the spectrum acquired from rough-
ened aluminum. The relationship between the intensity of
spectra from the aluminum and the tissue spectrum depends
on the tissue’s optical properties, which are unknown a pri-
ori. Therefore, we iteratively subtract the same aluminum
spectrum scaled by a range of different intensities to deter-
mine the optimal ratio for background removal. The spec-
trum that results in the lowest standard deviation of the re-
sidual between the data and the model fit is used for analysis.
After fiber background removal, the remaining broadband
tissue luminescence is removed by subtracting a slowly vary-
ing polynomial sixth order that is fit to the data.33 This final
correction results in the calibrated Raman spectrum of the
examination site. This spectrum is numerically arranged
into a standard set of wavenumber bins. It is analyzed with
the appropriate disease model, atherosclerosis40 or breast
cancer,
41
using ordinary least-squares, which provides the
relative fit coefficients of the various chemical/
morphological components of the tissue. The user can toggle
between the two different models, as mandated by the clini-
cal situation.
2. Reflectance and fluorescence
A similar sequence of steps is executed to extract reflec-
tance and fluorescence information. The DRS spectrum is
obtained from the raw reflectance spectrum by subtracting
the background spectrum and dividing by the background-
subtracted reflectance standard response, as specified by the
manufacturer. This ensures that the excitation/collection ge-
ometry of the probe is properly accounted for. The DRS
spectrum is fit to the model of Farrell et al.42 to extract the
DRS spectral parameters that characterize the scattering and
absorption coefficients Sec. III B 1. The IFS spectrum is
obtained from the raw fluorescence spectrum by subtracting
the background spectrum and applying the IFS extraction
formula from Zhang et al.,43 enabling extraction of IFS spec-
tral parameters that characterize the tissue fluorophores Sec.
III B 2.
G. Safety
The MMS system must adhere to strict safety guidelines.
For breast or artery studies, in the clinical environment, any
part of the system that enters the sterile field touches the
patient directly or indirectly must be kept sterile. Steriliza-
tion of the MMS probe was performed using cold-gas ethyl-
ene oxide. Furthermore, the excitation laser energies cannot
exceed predetermined maximum values, which are deter-
mined and safeguarded prior to entering the operating room.
The Xe flash lamp and the nitrogen laser are pulsed sources
and thus internally shuttered. The continuous-wave diode la-
ser beam is gated by means of a high-speed shutter also
controlled by LABVIEW. The shutter opens automatically just
before DAQ begins and closes immediately after acquisition
is complete. The shutter then remains closed until the system
receives a signal through LABVIEW for the next acquisition.
H. Clinical layout
In order for the MMS instrument to be operated in a
clinical environment, it needs to have a suitable portable lay-
out. The various components of the system described in Fig.
1 were optimally positioned on optical breadboards with the
help of SOLIDWORKS software. This modular placement was
used to confine the components within a metal enclosure
dimensions of 272758 in.3 that can be wheeled into
the operating room for clinical data collection. The layout
schematic and a photo of the finished instrument are pro-
vided in Fig. 3.
III. PROBE DESCRIPTION
The MMS probe design is a modification of the Raman
probe that enables efficient delivery and collection of DRS
and IFS in the UV/visible wavelength region, as well as Ra-
man in the near IR. Because the excitation/collection geom-
etry is altered from that of the FastEEM probe, the modeling
of DRS and IFS spectra collected with this probe must be
adjusted to enable correct extraction of spectral parameters.
A. MMS probe design
The MMS probe is similar to the Raman probe described
in detail elsewhere.33 A schematic is shown in Fig. 4a. The
MMS probe differs from the Raman probe in several ways:
1 the optical fibers that are used for delivery and collection,
2 the filter characteristics, and 3 the type of adhesives
used to glue the components in the probe tip.
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1. Optical fibers
Owing to the broad range of wavelengths of light used,
the MMS probe fibers need to be optimized for their particu-
lar modalities. The central excitation fiber must efficiently
transmit excitation light in the range of 300–830 nm, so a
Superguide fiber 200 m core diameter, 0.22 NA, Fiber-
guide Industries, Stirling, NJ is used. The collection fibers
need to be partitioned in a manner so as to provide sufficient
Raman return light at NIR wavelengths and reflectance/
fluorescence return light in the visible. The collection fibers
can thus be optimized based on modalities, so Superguide
fibers are used for the visible and Anhydroguide fibers
200 m core diameter, 0.26 NA, Fiberguide Industries,
Stirling, NJ are used for the NIR. Therefore, out of the 15
collection fibers, five fibers are employed for DRS/IFS,
while the remaining ten are used for the much weaker Raman
light. This allows almost equivalent signal collection with
the single MMS probe as with the individual FastEEM and
Raman probes used individually in previous studies.
2. Filter characteristics
The tiny filter module of the MMS probe must process
light properly in order that DRS, IFS, and NIR Raman spec-
troscopies can all be implemented. As shown in Fig. 4a, the
filter module is in the form of a fused silica rod 0.5 mm
diameter, 1 mm length, polished and dielectrically coated for
optimal light delivery surrounded by a snug-fitting fused
silica tube of 0.7 mm inner diameter, 1.8 mm outer diameter,
1 mm length, polished and dielectrically coated for optimal
light collection. The excitation fiber rod contains a short-pass
filter that efficiently transmits 300–830 nm wavelength light
and blocks light at wavelengths of 850 nm. The collection
fiber tube contains a notch filter that blocks light around
Raman excitation wavelength 800–850 nm while effi-
ciently transmitting 300–800 and 850–1000 nm wavelength.
These filter characteristics are shown in Fig. 4b. The filters
are custom manufactured Barr Associates, Westford, MA.
One should note that owing to the significant amount of
quartz Raman background generated in the fibers themselves
and the inherently weak Raman signals from tissue, the de-
scribed filters must be placed at the probe tip to enable the
extraction of Raman spectra; more details about the filters
can be found in Ref. 33.
3. Adhesives
Sodium silicate or epoxy was used in the Raman probe
to glue the rods and tubes to the fibers. Ultimately, epoxy
was deemed more effective as a result of its durability and
optical properties. However, ordinary epoxy is not optically
clear in the UV wavelength range. As a result, a special
epoxy Epo-tek 305, Epoxy Technology, Billerica, MA is
used for the MMS probe. Note that a sapphire ball lens is
still optimal for the MMS probe, as sapphire is optically
clear in the range of 300–1000 nm and its Raman features
occur at low wavenumbers, well below the Raman features
in the fingerprint of diagnostic interest. Also, in the MMS
FIG. 3. Color online Modular layout of the MMS instrument left and a
photo of the actual system right. The various components are indicated.
FIG. 4. Color online a Schematic of the MMS probe with a side view on
the left and a cross sectional view on the right. A central excitation fiber
200 m core diameter, 0.22 NA is optically isolated from the surrounding
15 collection fibers, ten of which 200 m core diameter, 0.26 NA collect
Raman spectra and five of which 200 m core diameter, 0.22 NA collect
DRS and IFS return light. The probe tip contains a module to filter the
excitation and collection light and a sapphire ball lens to optimize collec-
tion. b Filter characteristics of the MMS probe. The excitation fiber light is
filtered by a short-pass filter that transmits 300–830 nm light and blocks
light 850 nm. The collection fiber tube contains a notch filter that trans-
mits 300–800 and 850–1000 nm while blocking light around the Raman
laser line 830 nm.
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probe the ball lens is not glued in the probe but instead held
by means of a stainless steel retaining sleeve.
The ball lens has an antireflection coating at 830 nm to
substantially reduce reflection losses at the boundary be-
tween the fused silica fiber and the ball lens for Raman spec-
tra, while reflection losses at 337 nm 6% are acceptable
as fluorescence has much higher signal strength.
B. Probe calibration
In the past, reflectance and fluorescence spectra were
collected with an unfiltered FastEEM probe, consisting of six
collection fibers surrounding one excitation fiber, with a 1.5
mm long quartz shield at the tip. The probe geometry was
such that the excitation and collection spots on the sample
were in the form of partially overlapping circles. The diffuse
reflectance spectral model developed by Zonios et al.16 is
dependent on this probe geometry. Now, with the ball lens of
the MMS probe, the excitation/collection geometry has
changed specifically by increasing the spatial overlap be-
tween the excitation and collection regions and the range of
angles collected, as compared to the FastEEM probe. The
IFS modeling can, in principle, stay the same as that pre-
sented by Zhang et al.,43 with modifications of several probe-
specific parameters. Therefore, the modeling in this new
probe geometry for both DRS and IFS spectra was revisited
so that each MMS probe could be calibrated appropriately to
ensure accurate extraction of tissue parameters. Note that the
spectral modeling of the Raman signals collected with the
MMS probe is the same as for the previous Raman probes
since the excitation/collection geometry has not been
changed for this modality.
1. DRS modeling
Farrell et al.42 calculated the diffuse reflectance from a
narrow beam of light incident on the surface of a semi-
infinite turbid medium in the diffusion approximation. The
Green’s function for reflectance density, R ,r in units
mm−2, at a distance r from the point of incidence, depends
on tissue parameters: the absorption coefficient a, the
reduced scattering coefficient s, and A, a diffusion
model parameter that depends on the refractive index of the
tissue, which is assumed to be A3.2.16 In order to calculate
the calibrated reflectance collected by a probe, Rp, the
Green’s function must be integrated over the delivery and
collection areas characterized by the radius of delivery rd
and radius of collection rc and normalized by the delivery
area rd
2 to obtain the unitless quantity
Rp =
1
rd
2
0
2
dc
0
rc
rdr
0
2
dd
0
rd
R, r
− rrdr, 1
where r−r specifies the distance between a point on the
delivery area and a point on the collection area. Equation 1
can be evaluated numerically, but it can further simplified by
making the approximation of point source delivery rd1.
With this approximation, Zonios et al.16 obtained a closed
form solution for the reflectance collected by a FastEEM
probe, which was used for previous DRS modeling of the
FastEEM probe. As discussed below, this approach does not
hold for the MMS probe.
Our objective is to accurately extract s and a
from the observed reflectance spectrum of tissue. To do this,
rd and rc must be evaluated for a given probe, which can be
accomplished by means of the following calibration tech-
nique. Five physical tissue models “phantoms” were pre-
pared to mimic artery tissue reflectance properties. Polysty-
rene beads with 1 m diameter and 1% solids by volume
64030 Polysciences, Warrington, PA were used to simulate
scattering. The s values were calculated using a standard
MIE code that evaluates the total scattering cross section
s, which translated into s for the specified bead
solution.44 For biological tissue in the visible region, a is
dominated by hemoglobin absorption. Therefore, the phan-
toms were mixed with a solution of dry hemoglobin H0267,
Sigma-Aldrich, St. Louis, MO dissolved in de-ionized H2O.
The a parameter depends on the known extinction spec-
trum of hemoglobin, the concentration of hemoglobin cHb,
and the oxygen saturation of hemoglobin 	, which was taken
to be 100% for the phantoms, as the hemoglobin is com-
pletely oxygenated. The five phantoms included variations in
scattering amplitude and hemoglobin concentration similar
to that found in human artery tissue.45
The phantoms were mixed in small glass vials and thor-
oughly agitated to prevent clumping of the beads. Diffuse
reflectance spectra were then collected using the MMS probe
and instrument. The DRS spectra were obtained using the
following expression:
Rp,observed =
reflectance − background
spectralon − background/calibStd
, 2
where reflectance is the recorded reflectance spectrum
from the phantom, background is the background spec-
trum collected from an opaque cup of de-ionized water,
spectralon is the reflectance spectrum recorded from a
calibrated standard 20% reflectance standard, Labsphere
Inc., North Sutton, NH, and calibStd is the manufacturer-
specified response of the standard. In this way, the
Rp,observed is expressed in calibrated reflectance units.
The probe-specific rd and rc values were calculated
through an optimization that minimized the residual
Rp,observed−Rp2, where Rp,observed was obtained
from Eq. 2 and Rp was calculated by numerically evalu-
ating Eq. 1 with the known and specified values of s
and a. Although the optimal values of rd and rc varied
slightly across the five phantoms, we found for the particular
probe used that the intermediate values rd=0.45 mm and
rc=0.30 mm can model well all five phantoms. The values
obtained were slightly different for a second probe. These
average parameters also make physical sense, given the
MMS probe ball lens that specifies both delivery spot and
also a range of reflected angles that can couple into the col-
lection fibers. In contrast, poor agreement was observed be-
tween Rp,observed and Rp calculated using the simplified
closed form solution of Zonios et al.16 Thus, the Farrell
model of Eq. 1 rather than the Zonios model should be
used to model DRS spectra collected with the MMS probe.
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Once the calibrated values of rd and rc were obtained,
we were able to prospectively extract accurate values of
s and a from an unknown tissue sample. For this
purpose we used a lookup table in which DRS spectra are
generated by numerically integrating Eq. 1 over a range of
values of s and a while keeping the calibrated
probe-specific parameters rd and rc fixed. In this case, s
was calculated by a power law, A−B, with two free param-
eters A and B. In general, the choice of a depends on the
concentrations of the particular absorbers present in the tis-
sue and their extinction coefficients, but in the present case
hemoglobin is the dominant absorber, so a is then speci-
fied by quantities cHb and 	 defined earlier.
An unknown tissue spectrum is then compared to the
entries in the lookup table to obtain the optimal values of A,
B, cHb, and 	 that in turn specify s and a. To check
its accuracy, the lookup table was applied to the phantom
spectra, and the extracted spectral quantities s and a
were compared to the known measured quantities in the
phantom mix. The deviation between the two was on average
only a few percent, which demonstrates the accuracy of the
predictive fitting. Another way to prospectively extract the
absorption and scattering coefficients from an unknown tis-
sue sample is to find the optimal s and a that mini-
mize the residual Rp,observed−Rp2 for the fixed cali-
brated values of rd and rc. However, the optimization method
is computationally more intensive, as it involves multiple
numerical integrations of Eq. 1, which is why the lookup
table is preferred for real-time fitting applications.
2. IFS modeling
In addition to containing the emission spectrum of fluo-
rophores, raw tissue fluorescence is also distorted by absorp-
tion and scattering. Intrinsic fluorescence, on the other hand,
is defined as the signal free from this interference and is thus
a linear combination of the concentrations of the fluoro-
phores. Zhang et al.43 presented a method based on photon
migration for extracting IFS spectra from turbid media,
which built on the previously developed model of Wu et al.46
The IFS spectrum fxm is related to the experimentally
measured fluorescence spectrum Fxm and DRS spectrum
Rm by means of the following expression:43
fxm =
Fxm
1
sxl
	R0xR0m

x
m

1/2 Rx
R0x
	 Rm
R0m
+ 
m
 ,
3
where Rx is a constant obtained from Rp,observed at the
fluorescence excitation wavelength, R0x is a constant similar
to Rx but computed using Eq. 1 by setting a=0, R0m is
a spectrum evaluated from Rp,observed but for all needed
fluorescence emission wavelengths, and sx is evaluated at
the fluorescence excitation wavelength and is extracted from
s using the known value of anisotropy g. Finally, 
x and

m are evaluated at the excitation and all emission wave-
lengths, respectively, using 
=e−1, with =S1−g, for a
fixed parameter S and anisotropy g, and l is related to the
optical thickness of the sample. Once the IFS spectrum
fxm is extracted, it can be related to tissue fluorophores
that are relevant to disease diagnosis.
Of all these parameters, S and l are probe-specific pa-
rameters that need to be calibrated for a particular probe.
This was done in a similar fashion as described in the case of
DRS to calibrate rd and rc. First, a set of known phantoms
using polystyrene beads, hemoglobin, and furan for fluores-
cence was used to calibrate the values of S and l. In this
process, we determined that the optimal values of these pa-
rameters for one particular MMS probe were S=0.7 and l
=40 m. These probe-specific parameters were then held
fixed for the particular probe and used with Eq. 3 to extract
fxm prospectively from unknown samples. Once the cor-
rect IFS spectrum is extracted, it can be fit using least-
squares to a specific linear model of constituent spectra.
3. Raman modeling
The modeling of the Raman spectra is the same for the
MMS probe as it is for the previously developed Raman
probe, as nothing has been changed in the excitation/
collection geometry for this modality. The modeling remains
as described previously.33
IV. SYSTEM PERFORMANCE
We have used the clinical MMS instrument and probe
for in vivo and ex vivo studies to detect vulnerable plaques in
arteries and also to diagnose breast cancer. MMS spectra
were collected in approximately 5 s total: 2.5 s for Raman,
1 s for DRS, and 1 s for IFS, with a fraction of a sec-
ond consumed by switching between the three excitation
sources. Typical excitation powers utilized were 100 mW at
830 nm continuous-wave for Raman, seven white light
pulses of 2 J /pulse for DRS energy meter PD10, Ophir
Optronics, City, and seven pulses of 4 J /pulse at 337 nm
for IFS. Representative MMS spectra from artery tissue in
vivo during a carotid endarterectomy are shown in Fig. 5.
The signal-to-noise ratios of all three spectral modalities col-
lected by the MMS instrument and probe are equivalent to
those collected with the previous instruments. Physical pa-
rameters accurately extracted from this spectroscopy data
contain important information about disease status of tissue,
specifically in this case about plaque vulnerability. The de-
tailed clinical results from both of these studies will be pub-
lished elsewhere.
One should note that the light sources and camera detec-
tors used in the MMS system are identical to or newer ver-
sions of the ones used in the previous FastEEM and clinical
Raman systems. The main difference in data collection com-
pared to previous systems is the single MMS probe that is
used for all spectral measurements. However, since each
probe is calibrated, for each modality, using standards and/or
phantoms, any probe-specific effects on the signal are thus
neutralized. Consistent with proper calibration, we were able
to model and fit data collected with the MMS system equally
well as data collected with the previous systems.
043103-7 Šćepanović et al. Rev. Sci. Instrum. 80, 043103 2009
Downloaded 01 Oct 2010 to 18.51.3.135. Redistribution subject to AIP license or copyright; see http://rsi.aip.org/about/rights_and_permissions
V. CONCLUSION
We have developed an integrated MMS instrument and
unitary probe for simultaneously collecting reflectance, fluo-
rescence, and Raman spectra. The MMS instrument is de-
signed to be compact and portable and thus appropriately
suited for clinical applications. All the critical diagnostic
functionality of previous stand-alone Raman and FastEEM
instruments has been preserved, taking advantage of techno-
logical improvements to reduce the size and cost of the
system. It is easy to use and backward compatible with pre-
viously developed probes for Raman and reflectance/
fluorescence, contains a software platform that automates in-
strument calibration and data collection, and provides real-
time analysis capability.
The MMS probe has a ball lens tip and appropriate filters
at the tip to enable efficient collection of Raman signals, as
well as fluorescence and reflectance, over the entire 300–
1000 nm spectral range. The ability to collect reflectance,
fluorescence, and Raman signals at the same time from the
same location in tissue eliminates sampling error and enables
realistic clinical use. A probe with this excitation/collection
geometry has not been used previously to collect reflectance
and fluorescence spectra, and careful calibration is required
to enable the accurate extraction of spectral parameters.
This MMS system has been used recently to analyze
tissue in vivo, and results from those studies will be pub-
lished separately. Additional improvements to the system,
which include a spectrograph with two gratings that can be
used with a single CCD camera as well as a smaller diameter
MMS probe, will make the instrument more compact and
clinic-friendly.
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